U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

1.
Figure 3

Figure 3. The temperature effect in the kinetic of formalin-inactivation of EV71 virus.. From: Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates.

Purified E59/EV71 was inactivated by 0.025% (v/v) formalin at different temperature and the residual of virus infectivity was detected by plaque assay performed triplicate at different time points.

Ai-Hsiang Chou, et al. PLoS One. 2012;7(4):e34834.
2.
Figure 1

Figure 1. The growth profiles of Vero cell grown in serum-contain medium (SC) and different serum-free media (SF).. From: Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates.

Vero cells (2×105 cell/ml) was cultured in 75T-flask and counted for viable cell number every 24 hours (0, 24, 48, 72, 96, 120 and 144 hours). The conditions for cell culture were described in the section.

Ai-Hsiang Chou, et al. PLoS One. 2012;7(4):e34834.
3.
Figure 2

Figure 2. The optimization of the up-stream process for EV71 virus production.. From: Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates.

(A) The T-flask was seeded with either 1.0∼1.5×106 or 2.0∼2.5×106 Vero cells, then after 2–3 days the cells were infected by the different ratio of E59/EV71 virus. The effects of different M.O.I were detected in the kinetic profile of virus produced from Vero cell grown in the VP-SFM medium. (B) The consistency of 3 Lots of EV71 virus production in the roller bottles. Virus titer was detected every day by TCID50 for 5 days.

Ai-Hsiang Chou, et al. PLoS One. 2012;7(4):e34834.
4.
Figure 4

Figure 4. The stability profiles of different Lots of EV71 vaccine products stored at 4°C for various time and analyzed by SDS-PAGE (Panel A) and Western blot (Panel B & C).. From: Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates.

Lane M is MW Markers; lane 1 is EV71 vaccine product produced from serum-containing medium and stored at 4°C for 26 months; lanes 2 and 3 are EV71 vaccine products derived from Lot #1 and 2 and stored at 4°C for 13 and 4 months, respectively. Monoclonal antibody used in the Panels B and C are MAB979 specific for VP2 and N16 specific for VP1, respectively.

Ai-Hsiang Chou, et al. PLoS One. 2012;7(4):e34834.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center